Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options
Authors
Keywords
-
Journal
Biomedicines
Volume 10, Issue 9, Pages 2274
Publisher
MDPI AG
Online
2022-09-15
DOI
10.3390/biomedicines10092274
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetes-Induced Cellular Senescence and Senescence-Associated Secretory Phenotype Impair Cardiac Regeneration and Function Independently of Age
- (2022) Fabiola Marino et al. DIABETES
- Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus–A randomized, placebo-controlled cross-over study
- (2022) Hannah Elena Suhrs et al. PLoS One
- Targeting Protein O-GlcNAcylation, a Link between Type 2 Diabetes Mellitus and Inflammatory Disease
- (2022) Israel Bolanle et al. Cells
- Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy
- (2022) Yong-Wei Yu et al. Frontiers in Cardiovascular Medicine
- Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature
- (2022) Sharif A. Sabe et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Molecular mechanisms of coronary microvascular endothelial dysfunction in diabetes mellitus: focus on mitochondrial quality surveillance
- (2022) Danan Sun et al. ANGIOGENESIS
- Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management
- (2022) Mohamad B. Taha et al. Current Atherosclerosis Reports
- Study on Correlation between Type 2 Diabetes and No-Reflow after PCI
- (2022) Su-Rui Zhao et al. DISEASE MARKERS
- An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
- (2022) Teresa Salvatore et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Liraglutide prevents high glucose induced HUVECs dysfunction via inhibition of PINK1/Parkin-dependent mitophagy
- (2022) Yikai Zhang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction
- (2022) Seung Hun Lee et al. Journal of the American Heart Association
- Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway
- (2022) Chen Cai et al. Redox Biology
- The role of GLP-1 receptor agonists in managing type 2 diabetes
- (2022) Noura Nachawi et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Endothelial Cell Metabolic Memory Causes Cardiovascular Dysfunction In Diabetes
- (2021) Yufeng Yao et al. CARDIOVASCULAR RESEARCH
- In-Hospital Peak Glycemia in Predicting No-Reflow Phenomenon in Diabetic Patients with STEMI Treated with Primary Percutaneous Coronary Intervention
- (2021) Fang Liu et al. Journal of Diabetes Research
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
- (2021) Luca Rinaldi et al. Antioxidants
- Coronary Microvascular Dysfunction
- (2021) Shigeo Godo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated
- (2021) Muhammad Aetesam-ur-Rahman et al. BMC Cardiovascular Disorders
- Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes
- (2021) Ferdinando Carlo Sasso et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease
- (2021) Ferdinando Carlo Sasso et al. Cardiovascular Diabetology
- Whole plantar nerve conduction study: A new tool for early diagnosis of peripheral diabetic neuropathy
- (2021) Raffaele Galiero et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2021) Theresa A McDonagh et al. EUROPEAN HEART JOURNAL
- Sodium Glucose Co-Transporter 2 Inhibitors Ameliorate Endothelium Barrier Dysfunction Induced by Cyclic Stretch through Inhibition of Reactive Oxygen Species
- (2021) Xiaoling Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activation of Coronary Arteriolar PKCβ2 Impairs Endothelial NO-Mediated Vasodilation: Role of JNK/Rho Kinase Signaling and Xanthine Oxidase Activation
- (2021) Naris Thengchaisri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases
- (2021) Marco Giuseppe Del Buono et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload
- (2021) Masaaki Nakao et al. Scientific Reports
- Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial
- (2021) Mikkel Jürgens et al. Journal of the American Heart Association
- Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction
- (2021) Christopher J. Rush et al. JAMA Cardiology
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
- (2021) Teresa Salvatore et al. Biomedicines
- Micro-RNA 92a as a Therapeutic Target for Cardiac Microvascular Dysfunction in Diabetes
- (2021) Mostafa Samak et al. Biomedicines
- Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study
- (2020) Luigi Elio Adinolfi et al. ATHEROSCLEROSIS
- Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet
- (2020) Vijayakumar Sukumaran et al. Cardiovascular Diabetology
- ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’
- (2020) Teresa Padro et al. CARDIOVASCULAR RESEARCH
- Coronary microvascular dysfunction in hypertrophy and heart failure
- (2020) Paolo G Camici et al. CARDIOVASCULAR RESEARCH
- Metformin: An old drug against old age and associated morbidities
- (2020) Teresa Salvatore et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Impact of liraglutide on microcirculation in experimental diabetic cardiomyopathy
- (2020) Nehad Gamal Abdelrazik Soliman et al. ACTA HISTOCHEMICA
- New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury
- (2020) Jin Wang et al. ANGIOGENESIS
- Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation
- (2020) Detmar Kolijn et al. CARDIOVASCULAR RESEARCH
- Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence
- (2020) Marco Giuseppe Del Buono et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Sodium–glucose cotransporters: Functional properties and pharmaceutical potential
- (2020) Ryuhei Sano et al. Journal of Diabetes Investigation
- Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12‐Month Treatment
- (2020) Ignatios Ikonomidis et al. Journal of the American Heart Association
- Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia-reperfusion injury
- (2020) Jin Wang et al. Acta Pharmaceutica Sinica B
- Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
- (2020) Matthew J. Crowley et al. DIABETES CARE
- Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antivirals therapy. A prospective study.
- (2020) Luigi E Adinolfi et al. DIABETES OBESITY & METABOLISM
- Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium
- (2020) Donato Cappetta et al. PHARMACOLOGICAL RESEARCH
- Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
- (2020) Maria del Carmen Asensio Lopez et al. Scientific Reports
- Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis
- (2020) Jessica A. Huthmacher et al. DIABETES CARE
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy
- (2020) Raffaele Galiero et al. Journal of Diabetes Research
- Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus
- (2020) Davide Capodanno et al. CIRCULATION
- SGLT2 Inhibition Does Not Affect Myocardial Fatty Acid Oxidation or Uptake, But Reduces Myocardial Glucose Uptake and Blood Flow in Individuals With Type 2 Diabetes– a Randomized Double-Blind, Placebo-Controlled Crossover Trial
- (2020) Katrine M. Lauritsen et al. DIABETES
- Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin
- (2020) Giulia Ferrannini et al. EUROPEAN HEART JOURNAL
- Assessment and pathophysiology of microvascular disease: recent progress and clinical implications
- (2020) Stefano Masi et al. EUROPEAN HEART JOURNAL
- Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction
- (2020) Rio P. Juni et al. KIDNEY INTERNATIONAL
- Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?
- (2020) Teresa Salvatore et al. Biomedicines
- Endothelium structure and function in kidney health and disease
- (2019) Noemie Jourde-Chiche et al. Nature Reviews Nephrology
- A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)
- (2019) John J.V. McMurray et al. EUROPEAN JOURNAL OF HEART FAILURE
- Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis
- (2019) Hillel Sternlicht et al. CURRENT HYPERTENSION REPORTS
- Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study
- (2019) Ole Geir Solberg et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease
- (2019) Jaskanwal D. Sara et al. Cardiovascular Diabetology
- SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
- (2019) Damilola D. Adingupu et al. Cardiovascular Diabetology
- The GLP1 Receptor Agonist Liraglutide Protects Against Oxidized LDL‐Induced Endothelial Inflammation and Dysfunction via KLF2
- (2019) Wen Yue et al. IUBMB LIFE
- Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction
- (2019) Jasper Tromp et al. DIABETES CARE
- UCP2 protect the heart from myocardial ischemia/reperfusion injury via induction of mitochondrial autophagy
- (2019) Hui Wu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: a Meta-analysis of Randomized Controlled Trials
- (2019) Houyong Zhu et al. CLINICAL THERAPEUTICS
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study
- (2019) Luca Rinaldi et al. Journal of Translational Medicine
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Vasodilatory Actions of Glucagon-Like Peptide 1 Are Preserved in Skeletal and Cardiac Muscle Microvasculature but Not in Conduit Artery in Obese Humans With Vascular Insulin Resistance
- (2019) Nasui Wang et al. DIABETES CARE
- Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway
- (2019) Qingguo Lu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy
- (2018) Maura Knapp et al. ACTA PHARMACOLOGICA SINICA
- Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic mice
- (2018) Minglin Pan et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction
- (2018) Kathryn Dryer et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- FGF23 impairs peripheral microvascular function in renal failure
- (2018) Melissa Verkaik et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- NR4A1 aggravates the cardiac microvascular ischemia reperfusion injury through suppressing FUNDC1-mediated mitophagy and promoting Mff-required mitochondrial fission by CK2α
- (2018) Hao Zhou et al. BASIC RESEARCH IN CARDIOLOGY
- Exenatide exhibits anti-inflammatory properties and modulates endothelial response to tumor necrosis factor α-mediated activation
- (2018) Wojciech Garczorz et al. Cardiovascular Therapeutics
- Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2α-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy
- (2018) Hao Zhou et al. CELL DEATH AND DIFFERENTIATION
- The Vasculature in Prediabetes
- (2018) David H. Wasserman et al. CIRCULATION RESEARCH
- Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome
- (2018) Sergey Kachur et al. CURRENT HYPERTENSION REPORTS
- The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
- (2018) Merlin C. Thomas et al. DIABETOLOGIA
- Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66 Shc
- (2018) Sarah Costantino et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Remodeling of Wall Mechanics and the Myogenic Mechanism of Rat Intramural Coronary Arterioles in Response to a Short-Term Daily Exercise Program: Role of Endothelial Factors
- (2018) Mária Szekeres et al. JOURNAL OF VASCULAR RESEARCH
- Exenatide modulates metalloproteinase expression in human cardiac smooth muscle cells via the inhibition of Akt signaling pathway
- (2018) Enrique Gallego-Colon et al. Pharmacological Reports
- Hyperglycaemic impairment of PAR2-mediated vasodilation: Prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress
- (2018) Mahmoud El-Daly et al. VASCULAR PHARMACOLOGY
- Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms
- (2018) Sarah J. Mancini et al. Scientific Reports
- Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
- (2018) Hao Zhou et al. Redox Biology
- Short-term weight loss reverses obesity-induced microvascular endothelial dysfunction
- (2018) Tamas Csipo et al. GeroScience
- Incretin drugs as modulators of atherosclerosis
- (2018) Enrique Gallego-Colon et al. ATHEROSCLEROSIS
- Cardiovascular benefits of GLP-1 agonists in type 2 diabetes: a comparative review
- (2018) James G. Boyle et al. CLINICAL SCIENCE
- GLP-1 treatment protects endothelial cells from oxidative stress-induced autophagy and endothelial dysfunction
- (2018) Xiangsheng Cai et al. International Journal of Biological Sciences
- Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients
- (2018) Navkaranbir S. Bajaj et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The usefulness of short-term high-fat/high salt diet as a model of metabolic syndrome in mice
- (2018) Leônidas Graças Mendes-Junior et al. LIFE SCIENCES
- Exendin‑4 reverses endothelial dysfunction in mice fed a high‑cholesterol diet by a GTP cyclohydrolase‑1/tetrahydrobiopterin pathway
- (2018) Zhiqi Tang et al. Molecular Medicine Reports
- Weight loss associated with sodium-glucose cotransporter-2 inhibition: a review of evidence and underlying mechanisms
- (2018) P. C. Lee et al. Obesity Reviews
- Liraglutide Treatment Reduces Endothelial Endoplasmic Reticulum Stress and Insulin Resistance in Patients With Diabetes Mellitus
- (2018) Rosa Bretón‐Romero et al. Journal of the American Heart Association
- Role of local coronary blood flow patterns and shear stress on the development of microvascular and epicardial endothelial dysfunction and coronary plaque
- (2018) Gerasimos Siasos et al. CURRENT OPINION IN CARDIOLOGY
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Applicability of telemedicine in the screening of diabetic retinopathy (DR): The first multicentre study in Italy. The No Blind Study
- (2018) Ferdinando Carlo Sasso et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options
- (2018) Viviany R. Taqueti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global Coronary Flow Reserve Measured During Stress Cardiac Magnetic Resonance Imaging Is an Independent Predictor of Adverse Cardiovascular Events
- (2018) Raksha Indorkar et al. JACC-Cardiovascular Imaging
- GLP‐1 Is a Coronary Artery Vasodilator in Humans
- (2018) Sophie J. Clarke et al. Journal of the American Heart Association
- Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis
- (2018) Konstantinos Batzias et al. Journal of Diabetes Research
- Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy
- (2017) Yu Zhang et al. ENDOCRINE REVIEWS
- Position paper of the European Society of Cardiology–working group of coronary pathophysiology and microcirculation: obesity and heart disease
- (2017) Lina Badimon et al. EUROPEAN HEART JOURNAL
- Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials
- (2017) Suzanne de Waha et al. EUROPEAN HEART JOURNAL
- Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction
- (2017) Viviany R Taqueti et al. EUROPEAN HEART JOURNAL
- Interplay among H3K9-editing enzymes SUV39H1, JMJD2C and SRC-1 drives p66Shc transcription and vascular oxidative stress in obesity
- (2017) Sarah Costantino et al. EUROPEAN HEART JOURNAL
- Microvascular NADPH oxidase in health and disease
- (2017) Yao Li et al. FREE RADICAL BIOLOGY AND MEDICINE
- Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
- (2017) Eugene J Barrett et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Coronary microvascular dysfunction in diabetes mellitus
- (2017) Aleksandar Kibel et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study
- (2017) Roni Nielsen et al. JOURNAL OF NUCLEAR CARDIOLOGY
- Diabetes Mellitus–Induced Microvascular Destabilization in the Myocardium
- (2017) Rabea Hinkel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases
- (2017) Michael T. Osborne et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome
- (2017) Hicham Labazi et al. PHARMACOLOGICAL RESEARCH
- Incremental Value of Transthoracic Doppler Echocardiography‐Assessed Coronary Flow Reserve in Patients With Suspected Myocardial Ischemia Undergoing Myocardial Perfusion Scintigraphy
- (2017) Li‐Ming Gan et al. Journal of the American Heart Association
- Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function
- (2017) Nishant R. Shah et al. Journal of the American Heart Association
- Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage
- (2017) Mario Masarone et al. PLoS One
- Interaction of IL-6 and TNF-α contributes to endothelial dysfunction in type 2 diabetic mouse hearts
- (2017) Jonghae Lee et al. PLoS One
- Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner
- (2016) Rui Wei et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications
- (2016) Adam Harvey et al. CANADIAN JOURNAL OF CARDIOLOGY
- Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
- (2016) Manfredi Rizzo et al. Cardiovascular Diabetology
- Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
- (2016) Manasi S. Shah et al. CIRCULATION RESEARCH
- Persistent Microvascular Obstruction After Myocardial Infarction Culminates in the Confluence of Ferric Iron Oxide Crystals, Proinflammatory Burden, and Adverse RemodelingCLINICAL PERSPECTIVE
- (2016) Avinash Kali et al. Circulation-Cardiovascular Imaging
- Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca2+–XO–ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways
- (2016) Ying Zhang et al. FREE RADICAL BIOLOGY AND MEDICINE
- EMPA-REG – the “diuretic hypothesis”
- (2016) John McMurray JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- TNF and ROS Crosstalk in Inflammation
- (2016) Heiko Blaser et al. TRENDS IN CELL BIOLOGY
- The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice
- (2016) Kathryn E. Husarek et al. VASCULAR PHARMACOLOGY
- Bimodal Pattern of Coronary Microvascular Involvement in Diabetes Mellitus
- (2016) Murat Sezer et al. Journal of the American Heart Association
- Oxidative stress improves coronary endothelial function through activation of the pro-survival kinase AMPK
- (2016) Ehtesham Shafique et al. Aging-US
- Mst1 inhibits CMECs autophagy and participates in the development of diabetic coronary microvascular dysfunction
- (2016) Jie Lin et al. Scientific Reports
- Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
- (2015) Wei Ren Chen et al. AMERICAN HEART JOURNAL
- Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes – a randomized, single-blinded, cross-over pilot study
- (2015) Rebekka Faber et al. Cardiovascular Diabetology
- Cardiac Autoimmunity as a Novel Biomarker, Mediator, and Therapeutic Target of Heart Disease in Type 1 Diabetes
- (2015) Myra A. Lipes et al. Current Diabetes Reports
- Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
- (2015) Juraj Koska et al. DIABETES
- Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibition
- (2015) S. P. Rajeev et al. DIABETES OBESITY & METABOLISM
- Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis
- (2015) Feng Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
- (2015) C. Noel Bairey Merz et al. EUROPEAN HEART JOURNAL
- A randomised trial comparing the effect of exercise training and weight loss on microvascular function in coronary artery disease
- (2015) Rasmus Huan Olsen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 and Ghrelin Levels in Patients with Type 2 Diabetes: A Prospective Pilot Study
- (2015) Manfredi Rizzo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vascular nitric oxide: Beyond eNOS
- (2015) Yingzi Zhao et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coronary Microvascular Dysfunction, Microvascular Angina, and Management
- (2015) Adrián I. Löffler et al. Current Cardiology Reports
- Impaired Coronary and Renal Vascular Function in Spontaneously Type 2 Diabetic Leptin-Deficient Mice
- (2015) Helena U. Westergren et al. PLoS One
- Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways
- (2015) Kosuke Nagayama et al. PLoS One
- Low Coronary Microcirculatory Resistance Associated With Profound Hypotension During Intravenous Adenosine Infusion
- (2014) Mauro Echavarría-Pinto et al. Circulation-Cardiovascular Interventions
- GLP-1 at physiological concentrations recruits skeletal and cardiac muscle microvasculature in healthy humans
- (2014) Sharmila C. Subaran et al. CLINICAL SCIENCE
- GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans
- (2014) L. van Bloemendaal et al. DIABETES
- GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
- (2014) D. Beiroa et al. DIABETES
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
- (2014) Anna Secher et al. JOURNAL OF CLINICAL INVESTIGATION
- Adenosine-Mediated Effects of Ticagrelor
- (2014) Marco Cattaneo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prognostic Meaning of Coronary Microvascular Disease in Type 2 Diabetes Mellitus: A Transthoracic Doppler Echocardiographic Study
- (2014) Lauro Cortigiani et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- The Cardiovascular Effect of the Uremic Solute Indole-3 Acetic Acid
- (2014) L. Dou et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis
- (2014) Yuko Tashiro et al. PEPTIDES
- Endothelial NADPH oxidases: which NOX to target in vascular disease?
- (2014) Grant R. Drummond et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Nitric Oxide, Oxidative Stress, andp66ShcInterplay in Diabetic Endothelial Dysfunction
- (2014) Alessandra Magenta et al. Biomed Research International
- Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice
- (2013) Young-Eun Cho et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Electron Microscopic Evaluation of Internal Thoracic Artery Endothelial Morphology in Diabetic Coronary Bypass Patients
- (2013) Vedat Bakuy et al. ANNALS OF THORACIC SURGERY
- Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells
- (2013) Battsetseg Batchuluun et al. ATHEROSCLEROSIS
- Glucagon-Like Peptide-1 Protects Against Cardiac Microvascular Injury in Diabetes via a cAMP/PKA/Rho-Dependent Mechanism
- (2013) D. Wang et al. DIABETES
- Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model
- (2013) P. Richards et al. DIABETES
- Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines
- (2013) Alessandra Quercioli et al. EUROPEAN HEART JOURNAL
- A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
- (2013) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Akita Spontaneously Type 1 Diabetic Mice Exhibit Elevated Vascular Arginase and Impaired Vascular Endothelial and Nitrergic Function
- (2013) Haroldo A. Toque et al. PLoS One
- Glucagon-like peptide-1 preserves coronary microvascular endothelial function after cardiac arrest and resuscitation: potential antioxidant effects
- (2012) Betsy B. Dokken et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells
- (2012) Aya Shiraki et al. ATHEROSCLEROSIS
- Association Between Coronary Vascular Dysfunction and Cardiac Mortality in Patients With and Without Diabetes Mellitus
- (2012) Venkatesh L. Murthy et al. CIRCULATION
- Cyclic GMP-Dependent Signaling in Cardiac Myocytes
- (2012) Eiki Takimoto CIRCULATION JOURNAL
- Gene Silencing of the Mitochondrial Adaptor p66 Shc Suppresses Vascular Hyperglycemic Memory in Diabetes
- (2012) Francesco Paneni et al. CIRCULATION RESEARCH
- Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes
- (2012) Michael Horowitz et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes
- (2012) S. C. Elms et al. DIABETOLOGIA
- Cardiovascular Benefits of GLP-1-BasedTherapies in Patients with Diabetes Mellitus Type 2: Effects on Endothelial and Vascular Dysfunction beyond Glycemic Control
- (2012) Thomas Forst et al. Experimental Diabetes Research
- Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome
- (2012) Aaron J. Trask et al. JOURNAL OF APPLIED PHYSIOLOGY
- Exenatide Alters Myocardial Glucose Transport and Uptake Depending on Insulin Resistance and Increases Myocardial Blood Flow in Patients with Type 2 Diabetes
- (2012) M. Gejl et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Decreased coronary microvascular reactivity after cardioplegic arrest in patients with uncontrolled diabetes mellitus
- (2012) Jun Feng et al. SURGERY
- Differential coronary resistance microvessel remodeling between type 1 and type 2 diabetic mice: Impact of exercise training
- (2012) Aaron J. Trask et al. VASCULAR PHARMACOLOGY
- Is Discordance of Coronary Flow Reserve and Fractional Flow Reserve Due to Methodology or Clinically Relevant Coronary Pathophysiology?
- (2012) Nils P. Johnson et al. JACC-Cardiovascular Imaging
- Dysfunction of endothelium-dependent relaxation to insulin via PKC-mediated GRK2/Akt activation in aortas of ob/ob mice
- (2011) Kumiko Taguchi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness
- (2011) Paige S. Katz et al. BASIC RESEARCH IN CARDIOLOGY
- Altered Mitochondrial Dynamics Contributes to Endothelial Dysfunction in Diabetes Mellitus
- (2011) Sherene M. Shenouda et al. CIRCULATION
- Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve
- (2011) Venkatesh L. Murthy et al. CIRCULATION
- H 2 O 2 Is the Transferrable Factor Mediating Flow-Induced Dilation in Human Coronary Arterioles
- (2011) Yanping Liu et al. CIRCULATION RESEARCH
- A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
- (2011) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration: The Joslin 50-Year Medalist Study
- (2011) J. K. Sun et al. DIABETES CARE
- Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation
- (2011) John Lekakis et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells
- (2011) Saima Muzaffar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Diabetes mellitus and thrombosis
- (2011) Natale Vazzana et al. THROMBOSIS RESEARCH
- Endothelium-Dependent Coronary Vasodilatation Requires NADPH Oxidase-Derived Reactive Oxygen Species
- (2010) Jun Feng et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species–Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A
- (2010) Hisko Oeseburg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study
- (2010) Anne Gill et al. Cardiovascular Diabetology
- Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
- (2010) D. J. Drucker et al. DIABETES CARE
- Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes
- (2010) A. Makino et al. DIABETOLOGIA
- Effect of diet-induced weight loss on endothelial dysfunction: early improvement after the first week of dieting
- (2010) Alenka Mavri et al. HEART AND VESSELS
- Free Fatty Acids Induce Insulin Resistance in Both Cardiac and Skeletal Muscle Microvasculature in Humans
- (2010) Jia Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents
- (2010) Ippei Shimizu et al. JOURNAL OF CLINICAL INVESTIGATION
- Left ventricular remodeling early after correction of mitral regurgitation: Maintenance of stroke volume with decreased systolic indexes
- (2010) Elena A. Ashikhmina et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Effect of bariatric surgery on peripheral flow-mediated dilation and coronary microvascular function
- (2010) R. Nerla et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Retinopathy Signs in People without Diabetes
- (2010) Elvis Ojaimi et al. OPHTHALMOLOGY
- Glucagon-like peptide-1 (GLP-1) attenuates post-resuscitation myocardial microcirculatory dysfunction
- (2010) Betsy B. Dokken et al. RESUSCITATION
- Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members
- (2010) Jian Chen et al. Diabetes Therapy
- C-reactive protein impairs coronary arteriolar dilation to prostacyclin synthase activation: Role of peroxynitrite
- (2009) Travis W. Hein et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Role of EDHF in type 2 diabetes-induced endothelial dysfunction
- (2008) Yoonjung Park et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic mice
- (2008) Xue Gao et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Protein Modification by O-Linked GlcNAc Reduces Angiogenesis by Inhibiting Akt Activity in Endothelial Cells
- (2008) Bai Luo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Maturation-induces endothelial dysfunction via vascular inflammation in diabetic mice
- (2008) Cuihua Zhang et al. BASIC RESEARCH IN CARDIOLOGY
- Superoxide from NADPH oxidase upregulates type 5 phosphodiesterase in human vascular smooth muscle cells: inhibition with iloprost and NONOate
- (2008) S Muzaffar et al. BRITISH JOURNAL OF PHARMACOLOGY
- Microvascular Obstruction and the No-Reflow Phenomenon After Percutaneous Coronary Intervention
- (2008) Ronen Jaffe et al. CIRCULATION
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Tumor Necrosis Factor-α Downregulates Endothelial Nitric Oxide Synthase mRNA Stability via Translation Elongation Factor 1-α 1
- (2008) Guijun Yan et al. CIRCULATION RESEARCH
- Myocardial microcirculatory dysfunction after prolonged ventricular fibrillation and resuscitation
- (2008) Karl B. Kern et al. CRITICAL CARE MEDICINE
- An Integrated View of Insulin Resistance and Endothelial Dysfunction
- (2008) Ranganath Muniyappa et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Vascular smooth muscle cell signaling mechanisms for contraction to angiotensin II and endothelin-1
- (2008) Brandi M. Wynne et al. Journal of the American Society of Hypertension
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now